Miranda Toledano
Chief Executive Officer presso ENTERA BIO LTD.
Patrimonio netto: 453 840 $ in data 31/03/2024
Profilo
Miranda J.
Toledano is currently the Chief Executive Officer & Director at Entera Bio Ltd., the Director at Lipomedix Pharmaceuticals Ltd., and the Independent Director at Journey Medical Corp.
Previously, she held positions as the Chief Operating & Financial Officer, Director at TRIGR Therapeutics, Inc., the Independent Director at Compass Therapeutics, Inc., the Independent Director at NexGel, Inc., the Senior Manager at Ernst & Young (Israel) Ltd., the Vice President-Research at RP Management LLC, the Executive Vice President-Corporate Development at Sorrento Therapeutics, Inc., the Head-Healthcare Investment Banking at MLV & Co. LLC, and the Vice President-Investment Group at Royalty Pharma Plc.
Ms. Toledano obtained an undergraduate degree from Tufts University and an MBA from The Leonard N Stern School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
JOURNEY MEDICAL CORP.
0.57% | 21/07/2023 | 71 717 ( 0.57% ) | 263 919 $ | 31/03/2024 |
ENTERA BIO LTD.
0.31% | 01/03/2024 | 110 752 ( 0.31% ) | 184 956 $ | 31/03/2024 |
NEXGEL, INC.
0.03% | 17/08/2023 | 1 819 ( 0.03% ) | 4 966 $ | 31/03/2024 |
Posizioni attive di Miranda Toledano
| Società | Posizione | Inizio |
|---|---|---|
| ENTERA BIO LTD. | Chief Executive Officer | 15/07/2022 |
| JOURNEY MEDICAL CORPORATION | Director/Board Member | 01/05/2021 |
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Director/Board Member | 05/08/2019 |
Precedenti posizioni note di Miranda Toledano
| Società | Posizione | Fine |
|---|---|---|
| NEXGEL, INC. | Director/Board Member | 31/03/2024 |
| COMPASS THERAPEUTICS, INC. | Director/Board Member | 24/05/2022 |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2017 |
MLV & Co. LLC
 MLV & Co. LLC Investment Banks/BrokersFinance Founded in 2010, MLV & Co. LLC is a broker/dealer located in New York City. The firm is a direct subsidiary of FBR Capital Markets Holdings, Inc. and their ultimate parent is FBR & Co. (NASDAQ: FBRC), which acquired the firm in 2015. Their research focuses on small to mid-sized companies with disruptive technologies that have the potential to drive significant market changes. MLV & Co.'s coverage universe includes the life sciences, oil & gas and metals & mining sectors. | Corporate Officer/Principal | 01/09/2016 |
| ROYALTY PHARMA PLC | Chief Investment Officer | 01/01/2010 |
Formazione di Miranda Toledano
| Tufts University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| NEXGEL, INC. | Process Industries |
| ENTERA BIO LTD. | Health Technology |
| JOURNEY MEDICAL CORPORATION | Health Technology |
| ROYALTY PHARMA PLC | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young (Israel) Ltd. is an Israeli company that provides accounting services. The private company is based in Tel Aviv, Israel. | Commercial Services |
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Commercial Services |
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Health Technology |
TRIGR Therapeutics, Inc.
 TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Health Technology |
MLV & Co. LLC
MLV & Co. LLC Investment Banks/BrokersFinance Founded in 2010, MLV & Co. LLC is a broker/dealer located in New York City. The firm is a direct subsidiary of FBR Capital Markets Holdings, Inc. and their ultimate parent is FBR & Co. (NASDAQ: FBRC), which acquired the firm in 2015. Their research focuses on small to mid-sized companies with disruptive technologies that have the potential to drive significant market changes. MLV & Co.'s coverage universe includes the life sciences, oil & gas and metals & mining sectors. | Finance |
- Borsa valori
- Insiders
- Miranda Toledano
